HUTCHMED (China) Limited (HKG:0013)
Hong Kong · Delayed Price · Currency is HKD 24.54
-0.06 (-0.24%)
Jan 21, 2026, 1:35 PM HKT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 20.31 billion as of January 20, 2026. Its market cap has decreased by -1.08% in one year.
Market Cap
20.31B
Enterprise Value
10.71B
Revenue
4.73B
Ranking
n/a
PE Ratio
5.54
Stock Price
24.54
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 1.87B to 20.31B, an increase of 988.25%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 20.31B | 8.43% |
| Dec 31, 2025 | 18.73B | -4.11% |
| Dec 31, 2024 | 19.53B | -18.73% |
| Dec 29, 2023 | 24.03B | 14.66% |
| Dec 30, 2022 | 20.96B | -56.27% |
| Dec 31, 2021 | 47.93B | 35.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 249.91B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 116.20B |
| CSPC Pharmaceutical Group | 111.36B |
| Akeso | 108.05B |